Latest Industry Insights

The University of Aberdeen’s HPC usage rocketed by 50% during the height of the pandemic. In this insight, Dean Phillips, assistant director, digital and information services at the University explains how pioneering research was able to continue remotely when moved off campus.

In this instalment of Science Futures, we hear from Max Lennart Feuerstein. Max tells us more about his research and how it could drive technical enhancements of data acquisition workflows

Here we highlight some of the innovations featured at the 69^th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics.

In this interview, Alexandra Richardson tells us more about her research, the role that technology is playing in it and how important industry partnerships have been.

To find out more about how AI can improve melanoma diagnosis, Technology Networks spoke to Dr. Kiran Motaparthi, director of dermatopathology and clinical associate professor of dermatology at the University of Florida and Julianna Ianni, PhD, vice president of AI R&D, Proscia.

There is an inherent link between academia and industry that rarely gets the acknowledgement it deserves. Hear from a roundtable of PhD students on the impact that the collaborative relationship between academia and industry has on their work and the role that technology plays in the “Science Futures” initiative.

Technology Networks spoke with Peter Zipfell to learn more about the Innovation Summits and the key themes that will be explored at the events. In this interview, Peter also shares his thoughts on current trends in analytical technologies and software.

To learn more about the CMU Cloud Lab, the motivation behind the project and the benefits it will bring, Technology Networks spoke to Rebecca Doerge, PhD, dean, Mellon College of Science, Carnegie Mellon University, and Toby Blackburn, head of business development and research, Emerald Cloud Lab.

This article explores how the expanded use of systematic, collaborative registries should allow the medical device, pharmaceutical and oncology communities to gain additional momentum on the road toward personalized cancer care.

Technology Networks spoke to Linda De Jesus, senior vice president and chief commercial officer at Azenta Life Sciences to find out more about the announcement and how this will help drive innovation with greater speed and accuracy.